LHC Group, Inc. (LHCG) Receives $114.00 Average Target Price from Brokerages

Shares of LHC Group, Inc. (NASDAQ:LHCG) have been given an average rating of “Buy” by the fifteen ratings firms that are presently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $114.00.

Several brokerages have weighed in on LHCG. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, April 10th. BidaskClub lowered shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 28th. Barclays increased their price target on shares of LHC Group from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Thursday, March 21st. Craig Hallum increased their price target on shares of LHC Group from $93.00 to $114.00 and gave the company a “hold” rating in a research report on Friday, March 1st. They noted that the move was a valuation call. Finally, SunTrust Banks increased their price target on shares of LHC Group to $130.00 and gave the company a “buy” rating in a research report on Friday, March 1st.

NASDAQ LHCG opened at $104.99 on Friday. The stock has a market cap of $3.16 billion, a P/E ratio of 29.57, a PEG ratio of 1.75 and a beta of 0.91. LHC Group has a 52-week low of $67.72 and a 52-week high of $115.54. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.78 and a quick ratio of 1.78.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, February 27th. The health services provider reported $1.03 earnings per share for the quarter, hitting the consensus estimate of $1.03. LHC Group had a net margin of 3.50% and a return on equity of 8.40%. The company had revenue of $509.80 million for the quarter, compared to analyst estimates of $522.21 million. During the same period in the prior year, the business posted $0.62 earnings per share. The firm’s revenue for the quarter was up 75.1% compared to the same quarter last year. As a group, sell-side analysts predict that LHC Group will post 4.2 EPS for the current fiscal year.

In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction that occurred on Friday, February 1st. The shares were sold at an average price of $104.69, for a total transaction of $7,851,750.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Keith G. Myers sold 5,164 shares of the stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $108.75, for a total transaction of $561,585.00. Following the transaction, the chief executive officer now directly owns 96,315 shares in the company, valued at approximately $10,474,256.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 192,876 shares of company stock worth $20,614,290. 6.80% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of LHCG. Bank of New York Mellon Corp grew its position in LHC Group by 2.9% during the 3rd quarter. Bank of New York Mellon Corp now owns 732,075 shares of the health services provider’s stock worth $75,394,000 after purchasing an additional 20,567 shares during the period. Riverhead Capital Management LLC grew its position in LHC Group by 41.5% during the 3rd quarter. Riverhead Capital Management LLC now owns 3,069 shares of the health services provider’s stock worth $316,000 after purchasing an additional 900 shares during the period. LPL Financial LLC grew its position in LHC Group by 39.7% during the 3rd quarter. LPL Financial LLC now owns 4,043 shares of the health services provider’s stock worth $416,000 after purchasing an additional 1,149 shares during the period. Man Group plc grew its position in LHC Group by 116.3% during the 3rd quarter. Man Group plc now owns 59,403 shares of the health services provider’s stock worth $6,117,000 after purchasing an additional 31,940 shares during the period. Finally, MetLife Investment Advisors LLC grew its position in LHC Group by 47.0% during the 3rd quarter. MetLife Investment Advisors LLC now owns 20,894 shares of the health services provider’s stock worth $2,152,000 after purchasing an additional 6,685 shares during the period. 93.46% of the stock is currently owned by institutional investors.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.

Recommended Story: How to Invest in a Bull Market

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.